Total Payments
$747.35
2024 Payments
$30.18
Companies
14
Transactions
39
Medicare Patients
1,922
Medicare Billing
$129,767
Payment Breakdown by Category
Food & Beverage$728.36 (97.5%)
Education$18.99 (2.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $728.36 | 38 | 97.5% |
| Education | $18.99 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $180.27 | 12 | $0 (2022) |
| ABBVIE INC. | $118.29 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $103.38 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $77.59 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $53.12 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $52.53 | 2 | $0 (2022) |
| Hologic, LLC | $35.47 | 2 | $0 (2021) |
| Eisai Inc. | $23.78 | 1 | $0 (2020) |
| Medtronic, Inc. | $21.96 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $18.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30.18 | 1 | ABBVIE INC. ($30.18) |
| 2023 | $18.99 | 1 | Regeneron Healthcare Solutions, Inc. ($18.99) |
| 2022 | $338.40 | 19 | Novo Nordisk Inc ($149.87) |
| 2021 | $49.44 | 3 | Novo Nordisk Inc ($30.40) |
| 2020 | $23.78 | 1 | Eisai Inc. ($23.78) |
| 2019 | $190.12 | 9 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($103.38) |
| 2018 | $34.45 | 2 | GlaxoSmithKline, LLC. ($19.02) |
| 2017 | $61.99 | 3 | AstraZeneca Pharmaceuticals LP ($32.96) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Education | In-kind items and services | $18.99 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 12/14/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 10/04/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diabetes | ||||||
| 09/29/2022 | Ultragenyx Pharmaceutical Inc. | CRYSViTA (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/14/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $32.02 | General |
| Category: NEUROSCIENCE | ||||||
| 08/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: Diabetes | ||||||
| 06/21/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: NEUROSCIENCE | ||||||
| 03/23/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/22/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: VACCINES | ||||||
| 03/22/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 02/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 02/22/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.89 | General |
| Category: Diabetes | ||||||
| 02/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Cardiovascular | ||||||
| 02/04/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Diabetes | ||||||
| 01/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 01/20/2022 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $21.96 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 01/13/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 10/07/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 07/15/2021 | Hologic, LLC | THINPREP 2000 PROCESSOR (Device), APTIMA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Diagnostics | ||||||
| 09/22/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $23.78 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 266 | 301 | $88,643 | $22,441 |
| 2021 | 12 | 421 | 442 | $122,382 | $26,216 |
| 2020 | 22 | 1,235 | 1,435 | $409,139 | $81,110 |
Total Patients
1,922
Total Services
2,178
Medicare Billing
$129,767
Procedure Codes
44
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 55 | 74 | $29,635 | $6,939 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 80 | $21,905 | $4,715 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $13,097 | $4,507 | 34.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 18 | 18 | $11,010 | $3,144 | 28.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 21 | $5,750 | $1,250 | 21.7% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 15 | 16 | $2,676 | $532.55 | 19.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 14 | 14 | $448.00 | $435.33 | 97.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 14 | 14 | $1,820 | $406.13 | 22.3% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 19 | 19 | $1,282 | $368.07 | 28.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $1,021 | $143.88 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 100 | $40,047 | $7,858 | 19.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 39 | 39 | $16,780 | $5,421 | 32.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 82 | 89 | $24,369 | $4,902 | 20.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 17 | 17 | $10,760 | $2,990 | 27.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 46 | 47 | $12,869 | $1,650 | 12.8% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 38 | 38 | $3,360 | $1,137 | 33.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $9,037 | $919.84 | 10.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 40 | 40 | $1,280 | $716.46 | 56.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 19 | 19 | $1,282 | $375.63 | 29.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 15 | 15 | $1,276 | $175.14 | 13.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 11 | 11 | $935.99 | $43.33 | 4.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 12 | $384.72 | $27.00 | 7.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 403 | 489 | $133,893 | $21,398 | 16.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 190 | 220 | $88,103 | $16,196 | 18.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 43 | 43 | $27,216 | $7,710 | 28.3% |
About Dr. Walter Combs, MD
Dr. Walter Combs, MD is a Family Medicine healthcare provider based in Temecula, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104876598.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Combs, MD has received a total of $747.35 in payments from pharmaceutical and medical device companies, with $30.18 received in 2024. These payments were reported across 39 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($728.36).
As a Medicare-enrolled provider, Combs has provided services to 1,922 Medicare beneficiaries, totaling 2,178 services with total Medicare billing of $129,767. Data is available for 3 years (2020–2022), covering 44 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Temecula, CA
- Active Since 05/10/2006
- Last Updated 02/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1104876598
Products in Payments
- LifeVest (Device) $103.38
- Rybelsus (Drug) $89.02
- VRAYLAR (Drug) $60.92
- Ozempic (Drug) $60.85
- ELIQUIS (Drug) $53.12
- FARXIGA (Drug) $52.53
- SHINGRIX (Biological) $43.84
- BEXSERO (Biological) $33.75
- UBRELVY (Drug) $32.02
- RYBELSUS (Drug) $30.40
- LINZESS (Drug) $25.35
- Dayvigo (Drug) $23.78
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $21.96
- THINPREP 2000 PROCESSOR (Device) $19.04
- EVKEEZA (Biological) $18.99
- Coblation Wands (Device) $17.70
- CRYSViTA (Drug) $17.51
- Age based codes (Device) $16.43
- GYN Office Instrumental (Device) $15.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Temecula
Alwin Bagingito, M.d, M.D
Family Medicine — Payments: $13,525
Family Medicine $13,525
Dr. David Zebrack, D.o, D.O
Family Medicine — Payments: $12,323
Family Medicine $12,323
Consuelo Ocampo, Md, MD
Family Medicine — Payments: $7,426
Family Medicine $7,426
Dr. Sylvia Gisi, M.d, M.D
Family Medicine — Payments: $7,093
Family Medicine $7,093
Dr. Jonathan Vellinga, M.d, M.D
Family Medicine — Payments: $5,160
Family Medicine $5,160
Mrs. Kelly Boyatt, M.d, M.D
Family Medicine — Payments: $4,875
Family Medicine $4,875